University of Notre Dame du Lac’s Neurogene NGNE Stock Holding History

University of Notre Dame du Lac’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,738	Closed	-$569K	–	75
2018 Q2	$569K	Buy	10,738 +3,845	+56%	+$1M	0.11%	67
2018 Q1	$1.94M	Sell	6,893 -5,662	-45%	-$1.56M	0.36%	74
2017 Q4	$2.95M	Buy	12,555 +3,041	+32%	+$712K	0.61%	55
2017 Q3	$2.7M	Buy	9,514 +953	+11%	+$274K	0.75%	59
2017 Q2	$2.41M	Buy	+8,561	New	+$2.45M	0.71%	66

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

University of Notre Dame du Lac's NGNE Position: Q3 2018 in Review

University of Notre Dame du Lac sold out of Neurogene (NGNE) in Q3 2018, closing a stake of 10,738 shares — an estimated $569K sold.

University of Notre Dame du Lac first reported a position in NGNE in Q2 2017 and held it in 5 quarters. The position peaked at $2.95M in Q4 2017. 45 funds tracked by Wall St. Rank hold NGNE as of Q3 2018.

University of Notre Dame du Lac reported no remaining Neurogene position as of Q3 2018 after selling out during the quarter.
University of Notre Dame du Lac sold 10,738 Neurogene shares in Q3 2018, an estimated $569K.
University of Notre Dame du Lac first reported a position in Neurogene in Q2 2017 and held it in 5 quarters.
University of Notre Dame du Lac's Neurogene position peaked at $2.95M in Q4 2017.
45 funds tracked by Wall St. Rank held Neurogene as of Q3 2018.

Based on University of Notre Dame du Lac's 13F filing for Q3 2018, filed 13 Nov 2018.